- Barrons.com
Insulet Points Its Insulin Pump at the Big Diabetes Market: Type 2
Automated pumps are already used by about 40% of those with the autoimmune version of diabetes, known as Type-1.
- Zacks
Novo Nordisk (NVO) to Invest $4.1B in Clayton Facility Expansion
Novo Nordisk (NVO) plans to invest $4.1 billion in order to expand its Clayton facility with a second manufacturing plant, boosting capacity for injectable treatments and creating 1,000 new jobs.
- GuruFocus.com
From Sci-Fi Dream to Market Maze: Eli Lilly's Weight-Loss Medication Faces Hurdles
Assuming the rosier expectations will positively unfold, a reality check is done to compare the current valuation to informative financial ratios
© 2024 Yahoo. All rights reserved.